The U.S. Dept. of Health & Human Services (HHS) and Defense Dept. (DOD), awarded more than $562 million for COVID-19 test manufacturing.
As part of the American Rescue Plan to boost manufacturing of key products that increase domestic testing supply, the more than $562 million went to a dozen U.S. companies to support the production of supplies including pipette tips, protective packaging, swabs and reagents, according to a news release.
HHS and DOD’s investments follow President Joe Biden’s announcements of efforts to make COVID-19 testing more available to Americans, including a $3 billion investment into rapid testing to increase the supply of at-home tests by four times by December.
Here are the companies that received awards as part of the $562 million investment from the U.S. government:Nalge Nunc (Thermo Fisher Scientific subsidiary) – 192.5 million for domestic manufac…